Skip to content

Deferred income at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$64.84M+8.8%
Arteris, Inc. logo
Arteris, Inc.AIP
$6.16M-16.1%
XOMA Corporation logo
XOMA CorporationXOMA
$2.86M-30.0%
MP Materials logo
MP MaterialsMP
$24.52M+11.3%
LXP Industrial Trust logo
LXP Industrial TrustLXP
$2.72M-51.6%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.6M

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+111%
Enterprise value$1.07B+103%
P/S13.5×-1.3×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeNoncurrent.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's deferred income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's deferred income?
MeiraGTx Holdings plc (MGTX) reported deferred income of $64.84M in Q1 2026.
How has MeiraGTx Holdings plc's deferred income changed year-over-year?
MeiraGTx Holdings plc's deferred income increased by 8.8% year-over-year, from $59.62M to $64.84M.
What is the long-term trend for MeiraGTx Holdings plc's deferred income?
Over 3 years (2022 to 2025), MeiraGTx Holdings plc's deferred income has grown at a 33.4% compound annual growth rate (CAGR), from $27.44M to $65.12M.
What does deferred income mean?
This represents revenue or consideration received in advance for goods or services that will be delivered or performed in future periods beyond one year. It reflects non-cash liabilities arising from upfront payments, such as collaboration or licensing fees common in biotechnology partnerships. Tracking this helps investors understand the company's future revenue recognition potential and the nature of its long-term contractual obligations.